InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,316.80
(
-0.09%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
-0.24%
)
Bitcoin
62,843.67
(
-0.17%
)
Post# of 253167
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: BTH post# 153485

Tuesday, 12/04/2012 5:16:00 AM

Tuesday, December 04, 2012 5:16:00 AM

Post# of 253167

Looks like a couple other PD-1s have entered the clinic recently (besides Merck and BMS).

Two more older player: Teva has the rights to a PD-1 antibody, which is in phase II in 6 different cancer types and they will probably talk about phase III program on their analyst day next week (hope someone will listen and update cause I'll be away). RHHBY has one in phase I (NSCLC) and II (melanoma).
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up